NEO | Jotup

Mount Logan Capital Inc. Announces Continued Partnership with Specialized Credit Manager. Separately Announces Closing of Debenture Units Offering

Retrieved on:

Monday, January 29, 2024

Philosophy, MLC, Finance Secretary (India), Corporation, Partnership, Insurance, Warrant, Risk, Investment, Acquisition, Offering, CI Financial, NEO, Growth, Security (finance)

Separately, Mount Logan today announced the closing of an opportunistic $18.8 million privately placed debenture units offering through the issuance of 18,752 debenture units (“Debenture Units”) on a non-brokered private placement basis (the “Offering”).

Key Points:

Separately, Mount Logan today announced the closing of an opportunistic $18.8 million privately placed debenture units offering through the issuance of 18,752 debenture units (“Debenture Units”) on a non-brokered private placement basis (the “Offering”).
Since Mount Logan’s investment, Marret and Mount Logan have each benefited from access to broader credit investing skillsets.
Ted Goldthorpe, Chief Executive Officer and Chairman of Mount Logan, said, “A lot of strong momentum to start 2024 for Mount Logan.
Mount Logan shares our philosophy of delivering strong risk adjusted returns, and this partnership can create tremendous value for our clients.

Interfield Global Software Inc. Enters Into Non-Binding Memorandum of Understanding With JRL Energy Inc.

Retrieved on:

Thursday, January 18, 2024

Transaction, Partnership, Documentation, WIRE, ESG, Coal, Sale, NEO, NEWS, NOT

VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Interfield Global Software Inc. (NEO: IFSS) (the “Company”) announces that it has entered into a non-binding memorandum of understanding dated January 17, 2024 with JRL Energy Inc. (“JRL”), a major US energy company, for a strategic partnership to develop a digital platform for reporting operational data, environmental, social and governance ("ESG") reporting, energy transition reporting, and inventory management with respect to JRL’s coal production operations (the “Transaction”).

Key Points:

NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW
VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Interfield Global Software Inc. (NEO: IFSS) (the “Company”) announces that it has entered into a non-binding memorandum of understanding dated January 17, 2024 with JRL Energy Inc. (“JRL”), a major US energy company, for a strategic partnership to develop a digital platform for reporting operational data, environmental, social and governance ("ESG") reporting, energy transition reporting, and inventory management with respect to JRL’s coal production operations (the “Transaction”).
Completion of the Transaction is subject to the negotiation and execution of definitive documentation regarding licensing of the Company’s proprietary intellectual property and funding of the Transaction, as well as receipt of all regulatory approvals, including the approval of the NEO Exchange Inc., if applicable.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Cannabist Company Announces Debt Repurchase Agreement to Reduce Leverage by up to $25 Million

Retrieved on:

Monday, January 22, 2024

Natural Resources, Alternative Medicine, Other Retail, Health, Tobacco, Specialty, Cannabis, Retail, Agreement, Convertible, Repurchase agreement, Indian stock exchange, Exchange, NEO, CAD, Note, Security (finance)

“We are pleased to have reached agreement on the previously announced transaction to reduce leverage and decrease interest expense, maintaining momentum for our balance sheet improvement plan.

Key Points:

“We are pleased to have reached agreement on the previously announced transaction to reduce leverage and decrease interest expense, maintaining momentum for our balance sheet improvement plan.
We are grateful for the constructive relationship with our investors that enabled this transaction to come to fruition and look forward to delivering on additional initiatives in the months ahead,” said David Hart, CEO of The Cannabist Company.
In connection with the Repurchase, the Company obtained waivers from holders of, in the aggregate, US$34.5 million principal amount of 2025 Convertible Notes confirming that they did not object to the Company completing the Repurchase and confirming that they had no intention of participating in a Repurchase of their 2025 Convertible Notes on similar terms.
In connection with the Repurchase, ATB Capital Markets acted as exclusive financial advisor to the Company and to the Company’s special committee.

The Cannabist Company Teams up with Revelry to Bring the West Coast Lifestyle Cannabis and Retail Leader to the East Coast

Retrieved on:

Thursday, January 18, 2024

Retail, Cannabis, Other Travel, Travel, Sports, Other Retail, Agriculture, Tobacco, Natural Resources, Outdoors, Specialty, Alternative Medicine, Lifestyle, Consumer, Health, Seed, Partnership, NEO

Revelry’s cannabis products are currently only available in California, and this collaboration will be the first to introduce its flower brand to any East Coast market.

Key Points:

Revelry’s cannabis products are currently only available in California, and this collaboration will be the first to introduce its flower brand to any East Coast market.
The durable and functional designs of their products make the gear a customer favorite in our Cannabist locations throughout the country,” said Jesse Channon, President, The Cannabist Company.
Revelry will be supplying The Cannabist Company with exclusive, customized accessory products for its brands including Seed & Strain.
We know our products will be in good hands and can’t wait to embark on this exciting new journey.”

How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

Retrieved on:

Wednesday, January 24, 2024

PALM BEACH, Fla., Jan. 24, 2024 /PRNewswire/ -- The coming years could see a massive shift in the U.S. government's approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD). GAD is a prevalent mental health condition characterized by excessive and persistent worry, often extending beyond specific triggers. Individuals with GAD experience heightened levels of anxiety, anticipating future events and exhibiting physical symptoms such as muscle tension and restlessness. The disorder significantly impairs daily functioning and quality of life. A report from Delveinsight said that the total market size of the Generalized Anxiety Disorder (GAD) treatment market is anticipated to experience growth during the forecast period (2032) due to the emergence of new and effective treatments, especially numerous trials developing new and innovative next-generation psychedelic treatment options. The report added: "The diagnosis of Generalized Anxiety Disorder (GAD) involves a comprehensive assessment of an individual's mental health, considering the presence of excessive and uncontrollable worry across various aspects of life for a minimum of six months. Clinicians utilize standardized psychiatric interviews and validated screening tools to evaluate the severity of anxiety symptoms, along with a thorough exploration of associated physical and psychological manifestations. Differential diagnosis is crucial to rule out other psychiatric conditions, medical disorders, or substance-related issues that may mimic GAD symptoms. The diagnostic process also entails considering the impact of anxiety on daily functioning and its persistence in the absence of identifiable stressors. A multidimensional approach aids in ensuring an accurate diagnosis and facilitates the development of an effective treatment plan tailored to the individual's needs." Active Companies active today in markets include: Cybin Inc. (NYSE: CYBN) (NEO: CYBN), COMPASS Pathways plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), Seelos Therapeutics, Inc. (NASDAQ: SEEL), atai Life Sciences (NASDAQ: ATAI).

Key Points:

Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD).
It continued: "DelveInsight's analyst projects that among the total diagnosed prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM approximately 53% of cases were from the US.
The Generalized Anxiety Disorder (GAD) market is projected to witness consistent growth throughout the forecast period (2023–2032).
The market size of Generalized Anxiety Disorder (GAD) in the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies."

How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

Retrieved on:

Wednesday, January 24, 2024

PALM BEACH, Fla., Jan. 24, 2024 /PRNewswire/ -- The coming years could see a massive shift in the U.S. government's approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD). GAD is a prevalent mental health condition characterized by excessive and persistent worry, often extending beyond specific triggers. Individuals with GAD experience heightened levels of anxiety, anticipating future events and exhibiting physical symptoms such as muscle tension and restlessness. The disorder significantly impairs daily functioning and quality of life. A report from Delveinsight said that the total market size of the Generalized Anxiety Disorder (GAD) treatment market is anticipated to experience growth during the forecast period (2032) due to the emergence of new and effective treatments, especially numerous trials developing new and innovative next-generation psychedelic treatment options. The report added: "The diagnosis of Generalized Anxiety Disorder (GAD) involves a comprehensive assessment of an individual's mental health, considering the presence of excessive and uncontrollable worry across various aspects of life for a minimum of six months. Clinicians utilize standardized psychiatric interviews and validated screening tools to evaluate the severity of anxiety symptoms, along with a thorough exploration of associated physical and psychological manifestations. Differential diagnosis is crucial to rule out other psychiatric conditions, medical disorders, or substance-related issues that may mimic GAD symptoms. The diagnostic process also entails considering the impact of anxiety on daily functioning and its persistence in the absence of identifiable stressors. A multidimensional approach aids in ensuring an accurate diagnosis and facilitates the development of an effective treatment plan tailored to the individual's needs." Active Companies active today in markets include: Cybin Inc. (NYSE: CYBN) (NEO: CYBN), COMPASS Pathways plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), Seelos Therapeutics, Inc. (NASDAQ: SEEL), atai Life Sciences (NASDAQ: ATAI).

Key Points:

Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD).
It continued: "DelveInsight's analyst projects that among the total diagnosed prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM approximately 53% of cases were from the US.
The Generalized Anxiety Disorder (GAD) market is projected to witness consistent growth throughout the forecast period (2023–2032).
The market size of Generalized Anxiety Disorder (GAD) in the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies."

DeFi Technologies' Subsidiary Valour Inc. Announces Plans to Launch a Physical Backed ETP, the Valour HBAR Staking ETP in Collaboration with The Hashgraph Association (THA)

Retrieved on:

Monday, January 22, 2024

Bitcoin, Carbon, Cryptocurrency, XETRA, University, The Company, DLT, IBM, OTC, POS, Electronics, ETP, Standard Bank, Deutsche Telekom, Dell, Organization, NEO, LG Electronics, THA

Hedera's Significance: Hedera is a leading decentralized and open-source public network, notable for its energy-efficient Proof-of-Stake (PoS) consensus mechanism.

Key Points:

Hedera's Significance: Hedera is a leading decentralized and open-source public network, notable for its energy-efficient Proof-of-Stake (PoS) consensus mechanism.
Hedera is a decentralized, open-source, proof-of-stake public ledger that utilizes the leaderless, asynchronous Byzantine Fault Tolerance (aBFT) hashgraph consensus algorithm.
Valour also recently announced the launch of the 1Valour Bitcoin Physical Carbon Neutral ETP (ISIN: GB00BQ991Q22) on June 15, 2023.
Additionally, Valour offers fully hedged digital asset ETPs, with listings across European exchanges, banks, and broker platforms.

One Network Enterprises Announces an Enterprise Resource Planning (ERP) system for International Defense Organizations

Retrieved on:

Wednesday, January 17, 2024

ERP, APSR, ONE, Network, United States Marine Corps, Software, United States Air Force, Transport, Defense, NEO, ERPs, COTS, Risk management

DALLAS, Jan. 17, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce the release of its NEO Defense Enterprise Solution. The solution is an Enterprise Resource Planning (ERP) system uniquely designed for international defense organizations and military operations around the world.

Key Points:

DALLAS, Jan. 17, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce the release of its NEO Defense Enterprise Solution.
The solution is an Enterprise Resource Planning (ERP) system uniquely designed for international defense organizations and military operations around the world.
The NEO Defense Enterprise Solution is unlike any other commercial software solution deployed for Defense.
The NEO Defense Enterprise Solution is in production today, managing end-to-end munitions operations for both the US Air Force and US Marine Corps as their Accountable Property System of Record (APSR).

The Cannabist Company Announces Leadership Transition

Retrieved on:

Monday, January 15, 2024

“We all owe Nick a debt of gratitude for having the vision to form what is now The Cannabist Company more than a decade ago.

Key Points:

“We all owe Nick a debt of gratitude for having the vision to form what is now The Cannabist Company more than a decade ago.
We are excited for what lies ahead and eager to continue the progress as The Cannabist Company evolves, from continuing to strengthen the balance sheet to expanding our wholesale program and driving organic growth,” said David Hart, Chief Executive Officer of The Cannabist Company.
Vita co-founded The Cannabist Company, formerly Columbia Care, in 2012 when he became the Company’s first employee.
“The Cannabist Company would not exist as it does today without Nick and his fortitude to lead us through the peaks and valleys of running a cannabis company.

NEO Battery Materials Files 9th Silicon Anode Patent for Major Manufacturing Innovation

Retrieved on:

Thursday, January 11, 2024

Silicon, OEM, Shirin David, KIPO, NDA, Quality control, NEO, Patent, Silicone, Particle size, Electric battery

TORONTO, Jan. 11, 2024 (GLOBE NEWSWIRE) -- January 11, 2024 – (TSXV: NBM) (OTCQB: NBMFF)

Key Points:

TORONTO, Jan. 11, 2024 (GLOBE NEWSWIRE) -- January 11, 2024 – (TSXV: NBM) (OTCQB: NBMFF)
6 NDAs Secured with Global Chemical Material, Automotive OEM, and Battery Cell Manufacturers
NEO Battery Materials Ltd. (“NEO” or the “Company”), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that the Company has filed the 9th patent regarding a significant development in the silicon anode manufacturing process.
NEO Battery Materials has submitted the 9th patent entitled Silicone composite manufacturing method to the Korean Intellectual Property Office (KIPO).
This patent protects a significant innovation in the manufacturing process of NEO’s proprietary silicon anode materials, NBMSiDE®.
We aim to create comprehensive protection that precludes any replication attempt from final silicon anode products, nanocoating materials, and value-added projects.